Health
Nasal spray to fight COVID-19 could be manufactured in Australia – Manufacturers’ Monthly
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, backed by the $500 million Biomedical Translation Fund.
A nasal treatment for COVID-19, common colds and flu is being taken to the next stage of testing, with backing from the federal government’s $500 million Biomedical Translation Fund.
Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens into the body.
The government, with Brandon Capital Partners has committed $11.7 million to test the nasal spray treatment, that targets the primary…
-
Business17 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
General24 hours agoMichael Beatty, veteran current affairs journalist and animal welfare advocate, dies aged 76
-
Noosa News14 hours agoTips to improve engagement – Proctor
-
Noosa News17 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland